로딩 중…
지수 로딩 중…
파인메딕스
387570· KOSDAQ· Health Care· Health Care Equipment & Services
₩6,090-3.18%
2026-06-19
Price Chart
파인메딕스-19.55%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 34.26B KRW |
| Revenue | 9.86B KRW |
| Net Income | 465.5M KRW |
| Total Assets | 24.49B KRW |
| Net Assets | 18.31B KRW |
| Employees | 74 |
| Value | |
| P/E | 73.60x |
| P/B | 1.87x |
| P/S | 3.48x |
| FCF Yield | -10.17% |
| Profitability | |
| ROE | 2.54% |
| ROA | 1.90% |
| Op. Margin | -11.21% |
| Revenue Growth | 17.54% |
| Financial Health | |
| Debt Ratio | 133.76% |
| Total Debt | 2.99B KRW |
| FCF | -3.49B KRW |
| Cash | 4.64B KRW |
| Current Ratio | 5.78x |
| Performance | |
| 1Y Return | -19.55% |
| 1M Return | -5.73% |
| From 52W High | -36.10% |
| 1Y MDD | -39.46% |
| Trading | |
| Volume | 8,262 shares |
| Foreign Own. | 1.17% |
| Per Share | |
| EPS | -334 KRW |
| BPS | 3,372 KRW |
Company Info
Fine Medic, established in 2009, is a specialized manufacturer of advanced digestive endoscopic procedure instruments, listed on KOSDAQ in 2024. The company has localized endoscopic incision knives, snares, and injectors, securing over 20% domestic market share and expanding sales in Japan, Europe, and the U.S. based on CE and FDA certifications. Leveraging the CEO's more than 20 years of clinical experience, Fine Medic has established a unified development system to promptly productize the needs of the medical field. It is headquartered in Dong-gu, Daegu Metropolitan City.